Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
The Chronic Kidney Disease (CKD) is a major public health problem with its prevalence increasing especially in low-middle income countries (LMIC). Most of the cases of CKD are detected in the later stages and the patient may not have the resources for the treatment of End Stage Renal Disease (ESRD) in LMIC like Nepal. The early detection and treatment in the community is a crucial step in preventing the progression to ESRD. The study aims at identifying the prevalence of CKD through community screening, identifying various risk factors and its treatment received.
The data was collected from the database of Kidney Hypertension Diabetes Cardiovascular Disease (KHDC) which is a community outreach program working for prevention, early detection and management of CKD, Hypertension, Diabetes and Cardiovascular disease in the community of Eastern Nepal. The total number of participants were 17,082 in the period of 2009-2019. The structured questionnaire was used to obtain demographic data, risk factors, health status and physical examination along with the measurement of blood pressure. Dipstick was used to detect proteinuria and subsequently confirmed though Albumin Creatinine Ratio (ACR). Blood was collected to measure fasting blood glucose and serum creatinine. e-GFR was calculated using MDRD equation.
Mean age of participant was 56.80 years. Female constituted 60.6%. Hypertension, diabetes mellitus (DM), overweight, obesity and family history of kidney disease were found in 12%, 5.8%, 17%, 30.4% and 2.2% respectively. 11.7% of the participants were smokers. Proteinuria was detected in 3.5% and e-GFR ≤ 60 was detected in 18.6%. Both proteinuria and e-GFR ≤ 60 was detected in 1.2%. The participants with DM and hypertension who were receiving treatment were found to be 4.3% and 7.9% respectively. CKD was detected in 0.51% of participants with DM and in 0.84% with hypertension. Out of participants with proteinuria, 0.04% were receiving treatment whereas 0.18% of participants with e-GFR ≤ 60 were receiving treatment. 0.01% of participants with both proteinuria and e-GFR ≤ 60 were receiving treatment. All participants who were screened positive were managed as per context specific guidelines.
Prevalence of CKD and its risk factors is high in this study, although in the Nepalese context, e-GFR MDRD equation has not been validated yet. Most of the patients with CKD and its risk factors are not receiving the treatment. Community awareness and engagement along with the implementation of the existing guideline can help in early detection and management of CKD and its risk factor in countries with limited resources.
